These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

544 related items for PubMed ID: 18646008

  • 1. Hepatocyte growth factor and Met in tumor biology and therapeutic approach with NK4.
    Matsumoto K, Nakamura T, Sakai K, Nakamura T.
    Proteomics; 2008 Aug; 8(16):3360-70. PubMed ID: 18646008
    [Abstract] [Full Text] [Related]

  • 2. HGF/NK4, a four-kringle antagonist of hepatocyte growth factor, is an angiogenesis inhibitor that suppresses tumor growth and metastasis in mice.
    Kuba K, Matsumoto K, Date K, Shimura H, Tanaka M, Nakamura T.
    Cancer Res; 2000 Dec 01; 60(23):6737-43. PubMed ID: 11118060
    [Abstract] [Full Text] [Related]

  • 3. Mechanisms and significance of bifunctional NK4 in cancer treatment.
    Matsumoto K, Nakamura T.
    Biochem Biophys Res Commun; 2005 Jul 29; 333(2):316-27. PubMed ID: 15950947
    [Abstract] [Full Text] [Related]

  • 4. Inhibition of growth, invasion, and metastasis of human pancreatic carcinoma cells by NK4 in an orthotopic mouse model.
    Tomioka D, Maehara N, Kuba K, Mizumoto K, Tanaka M, Matsumoto K, Nakamura T.
    Cancer Res; 2001 Oct 15; 61(20):7518-24. PubMed ID: 11606388
    [Abstract] [Full Text] [Related]

  • 5. Suppression of tumor growth, invasion and angiogenesis of human gastric cancer by adenovirus-mediated expression of NK4.
    Heideman DA, van Beusechem VW, Bloemena E, Snijders PJ, Craanen ME, Offerhaus GJ, Derksen PW, de Bruin M, Witlox MA, Molenaar B, Meijer CJ, Gerritsen WR.
    J Gene Med; 2004 Mar 15; 6(3):317-27. PubMed ID: 15026993
    [Abstract] [Full Text] [Related]

  • 6. Inhibition of tumor growth and invasion by a four-kringle antagonist (HGF/NK4) for hepatocyte growth factor.
    Date K, Matsumoto K, Kuba K, Shimura H, Tanaka M, Nakamura T.
    Oncogene; 1998 Dec 10; 17(23):3045-54. PubMed ID: 9881707
    [Abstract] [Full Text] [Related]

  • 7. Induction of hepatocyte growth factor in fibroblasts by tumor-derived factors affects invasive growth of tumor cells: in vitro analysis of tumor-stromal interactions.
    Nakamura T, Matsumoto K, Kiritoshi A, Tano Y, Nakamura T.
    Cancer Res; 1997 Aug 01; 57(15):3305-13. PubMed ID: 9242465
    [Abstract] [Full Text] [Related]

  • 8. Hepatic gene expression of NK4, an HGF-antagonist/angiogenesis inhibitor, suppresses liver metastasis and invasive growth of colon cancer in mice.
    Wen J, Matsumoto K, Taniura N, Tomioka D, Nakamura T.
    Cancer Gene Ther; 2004 Jun 01; 11(6):419-30. PubMed ID: 15017381
    [Abstract] [Full Text] [Related]

  • 9. Inhibition of angiogenesis and HGF-cMET-elicited malignant processes in human hepatocellular carcinoma cells using adenoviral vector-mediated NK4 gene therapy.
    Heideman DA, Overmeer RM, van Beusechem VW, Lamers WH, Hakvoort TB, Snijders PJ, Craanen ME, Offerhaus GJ, Meijer CJ, Gerritsen WR.
    Cancer Gene Ther; 2005 Dec 01; 12(12):954-62. PubMed ID: 15905856
    [Abstract] [Full Text] [Related]

  • 10. Inhibition of tumor cell growth, invasion, and metastasis by EXEL-2880 (XL880, GSK1363089), a novel inhibitor of HGF and VEGF receptor tyrosine kinases.
    Qian F, Engst S, Yamaguchi K, Yu P, Won KA, Mock L, Lou T, Tan J, Li C, Tam D, Lougheed J, Yakes FM, Bentzien F, Xu W, Zaks T, Wooster R, Greshock J, Joly AH.
    Cancer Res; 2009 Oct 15; 69(20):8009-16. PubMed ID: 19808973
    [Abstract] [Full Text] [Related]

  • 11. NK4 gene therapy targeting HGF-Met and angiogenesis.
    Matsumoto K, Nakamura T.
    Front Biosci; 2008 Jan 01; 13():1943-51. PubMed ID: 17981681
    [Abstract] [Full Text] [Related]

  • 12. Antagonistic effect of NK4, a novel hepatocyte growth factor variant, on in vitro angiogenesis of human vascular endothelial cells.
    Jiang WG, Hiscox SE, Parr C, Martin TA, Matsumoto K, Nakamura T, Mansel RE.
    Clin Cancer Res; 1999 Nov 01; 5(11):3695-703. PubMed ID: 10589789
    [Abstract] [Full Text] [Related]

  • 13. Kringle 1-4 of hepatocyte growth factor inhibits proliferation and migration of human microvascular endothelial cells.
    Kuba K, Matsumoto K, Ohnishi K, Shiratsuchi T, Tanaka M, Nakamura T.
    Biochem Biophys Res Commun; 2000 Dec 29; 279(3):846-52. PubMed ID: 11162438
    [Abstract] [Full Text] [Related]

  • 14. [Effect of transferred NK4 gene on biological characteristics of human pancreatic cancer cell line SW1990].
    Lai RX, Yuan SZ, Nakamura T.
    Ai Zheng; 2004 Oct 29; 23(10):1134-8. PubMed ID: 15473922
    [Abstract] [Full Text] [Related]

  • 15. Inhibition of intracerebral glioblastoma growth by local treatment with the scatter factor/hepatocyte growth factor-antagonist NK4.
    Brockmann MA, Papadimitriou A, Brandt M, Fillbrandt R, Westphal M, Lamszus K.
    Clin Cancer Res; 2003 Oct 01; 9(12):4578-85. PubMed ID: 14555533
    [Abstract] [Full Text] [Related]

  • 16. Adenoviral-mediated gene transduction of the hepatocyte growth factor (HGF) antagonist, NK4, suppresses peritoneal metastases of gastric cancer in nude mice.
    Ueda K, Iwahashi M, Matsuura I, Nakamori M, Nakamura M, Ojima T, Naka T, Ishida K, Matsumoto K, Nakamura T, Yamaue H.
    Eur J Cancer; 2004 Sep 01; 40(14):2135-42. PubMed ID: 15341989
    [Abstract] [Full Text] [Related]

  • 17. Inhibition of colon cancer growth and metastasis by NK4 gene repetitive delivery in mice.
    Wen J, Matsumoto K, Taniura N, Tomioka D, Nakamura T.
    Biochem Biophys Res Commun; 2007 Jun 22; 358(1):117-23. PubMed ID: 17467663
    [Abstract] [Full Text] [Related]

  • 18. NK4, a four-kringle antagonist of HGF, inhibits spreading and invasion of human pancreatic cancer cells.
    Maehara N, Matsumoto K, Kuba K, Mizumoto K, Tanaka M, Nakamura T.
    Br J Cancer; 2001 Mar 23; 84(6):864-73. PubMed ID: 11259105
    [Abstract] [Full Text] [Related]

  • 19. Fully human monoclonal antibodies to hepatocyte growth factor with therapeutic potential against hepatocyte growth factor/c-Met-dependent human tumors.
    Burgess T, Coxon A, Meyer S, Sun J, Rex K, Tsuruda T, Chen Q, Ho SY, Li L, Kaufman S, McDorman K, Cattley RC, Sun J, Elliott G, Zhang K, Feng X, Jia XC, Green L, Radinsky R, Kendall R.
    Cancer Res; 2006 Feb 01; 66(3):1721-9. PubMed ID: 16452232
    [Abstract] [Full Text] [Related]

  • 20. The scatter factor/hepatocyte growth factor: c-met pathway in human embryonal central nervous system tumor malignancy.
    Li Y, Lal B, Kwon S, Fan X, Saldanha U, Reznik TE, Kuchner EB, Eberhart C, Laterra J, Abounader R.
    Cancer Res; 2005 Oct 15; 65(20):9355-62. PubMed ID: 16230398
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 28.